Biogipuzkoa
Centro de investigación
![Foto de Biogipuzkoa](/img/uploaded/BB680065D0326B877226AAACFBE7F51A.png)
![Foto de Sahlgrenska University Hospital](/img/noimage_org.png)
Sahlgrenska University Hospital
Gotemburgo, SueciaPublicaciones en colaboración con investigadores/as de Sahlgrenska University Hospital (73)
2024
-
A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors
Alzheimer's Research and Therapy, Vol. 16, Núm. 1
-
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure
Annals of Clinical and Translational Neurology, Vol. 11, Núm. 6, pp. 1541-1556
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
Computers in Biology and Medicine, Vol. 176
-
Serum Neurofilament Light Chain in Replication Factor Complex Subunit 1 CANVAS and Disease Spectrum
Movement Disorders, Vol. 39, Núm. 1, pp. 209-214
2023
-
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology
Alzheimer's and Dementia, Vol. 19, Núm. 3, pp. 807-820
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain
Pain Management, Vol. 13, Núm. 2, pp. 115-127
-
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 36
-
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Alzheimer's and Dementia, Vol. 19, Núm. 8, pp. 3350-3364
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
-
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients
British Journal of Surgery, Vol. 110, Núm. 12, pp. 1863-1876
-
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331
2022
-
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia
Annals of Clinical and Translational Neurology, Vol. 9, Núm. 11, pp. 1764-1777
-
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
Molecular neurodegeneration, Vol. 17, Núm. 1, pp. 27
-
Concerted alterations of functional connectivity and WM integrity in relationship to early amyloid deposition
Alzheimer's and Dementia
-
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)
Molecular Neurodegeneration
-
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
Alzheimer's Research and Therapy, Vol. 14, Núm. 1
-
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 14, Núm. 1